Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
Recruiting now · Not applicable
Conditions studied: Leukemia, Stem Cell Transplant, Cord Blood
In brief
To determine if the novel regimen of PT/FLU+CY promotes cord blood engraftment in children's leukemia HSCT cohort
Key facts
- Study ID
- NCT06155188
- Run by
- Nanfang Hospital, Southern Medical University
- People needed
- 60
- Starts
- 2019-09-29
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2023-12-04
Who can join
Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- children acute leukemia
You may not qualify if…
- MODS
Where it is running
- Nanfang Hospital — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.